KalVista Pharmaceuticals, Inc. (KALV)
NASDAQ: KALV · Real-Time Price · USD
12.09
+0.34 (2.89%)
Apr 17, 2025, 4:00 PM EDT - Market closed
KalVista Pharmaceuticals Market Cap
KalVista Pharmaceuticals has a market cap or net worth of $596.59 million as of April 17, 2025. Its market cap has increased by 25.60% in one year.
Market Cap
596.59M
Enterprise Value
349.17M
1-Year Change
25.60%
Ranking
Category
Stock Price
$12.09
Market Cap Chart
Since April 9, 2015, KalVista Pharmaceuticals's market cap has increased from $129.30M to $596.59M, an increase of 361.40%. That is a compound annual growth rate of 16.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 596.60M | 42.52% |
| Dec 31, 2024 | 418.60M | -1.11% |
| Dec 29, 2023 | 423.30M | 154.39% |
| Dec 30, 2022 | 166.40M | -48.59% |
| Dec 31, 2021 | 323.70M | -4.99% |
| Dec 31, 2020 | 340.70M | 7.27% |
| Dec 31, 2019 | 317.60M | -6.64% |
| Dec 31, 2018 | 340.20M | 223.69% |
| Dec 29, 2017 | 105.10M | 690.23% |
| Dec 30, 2016 | 13.30M | -86.04% |
| Dec 31, 2015 | 95.30M | -26.30% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.35B |
| UnitedHealth Group | 419.40B |
| Johnson & Johnson | 381.65B |
| AbbVie | 308.35B |
| Novo Nordisk | 284.50B |
| Abbott Laboratories | 228.84B |
| AstraZeneca | 210.38B |
| Novartis AG | 210.23B |